Kyrsten Sinema takes thousands in campaign contributions from pharmaceutical giants while stalling p
prescription drug pricing reforms
Sen. Kyrsten Sinema of Arizona is said to be opposed to the current prescription drug pricing proposals in bills put forth by both the House and Senate, as well as an alternative from House centrists that would limit the drugs subject to Medicare negotiation, according to unnamed sources cited by Politico.
Sinema's stance has stalled the passage of the $3.5 trillion spending bill crafted by the Biden administration and fellow Democrats, even though it could jeopardize her own bipartisan infrastructure bill. Democratic Rep. Pramila Jayapal of Washington has previously said the majority of the Congressional Progressive Caucus, which she chairs, would not vote for Sinema's infrastructure bill without first passing the spending package.
If passed, the $3.5 trillion spending bill would lower the cost of certain prescription drugs by instituting reforms and allowing Medicare to negotiate prices, which would save the federal government "hundreds of billions" on health care spending, according to a memo for Democratic senators.
Sinema is a "pharma favorite in Congress"
Since launching her political career, Sinema's campaign committee has received more than $500,000 in donations from the pharmaceutical and health product industries, according to OpenSecrets.
https://www.yahoo.com/news/kyrsten-sinema-takes-thousands-campaign-183332845.html